How Much Exosome Is Enough? Why Concentration Beats Particle Count

The exosome skincare market has grown fast. And with that growth has come a wave of products making bold numerical claims - “5 billion exosomes,” “10 billion exosomes,” “more than any other formula on the market.” It sounds impressive. It is also, scientifically speaking, not a reliable measure of anything meaningful.

This blog exists to explain why - clearly, specifically, and with the science to back it up. Particle count is not a standard measure of exosome serum quality. Concentration is. And beyond concentration, the source of the exosomes, the supporting formula, and the clinical evidence behind the product are what actually determine whether a serum delivers real results.

If you are shopping for an exosome serum and wondering what the numbers on the label actually mean, this guide covers everything you need to know: what concentration means in practice, why counting methods produce unreliable and non-comparable data, how source quality shapes biological activity, what good clinical evidence actually looks like, and how to read a label with the confidence of someone who understands the science. Browse the full exosome range to see how these principles apply in practice.

Our Exosome Glow Serum (£20 / 30ml) is built around 1% Cica Exosome complex - a plant-derived, clinically tested formulation where every claim is sourced and specific.

Exosome Concentration Explained: The Metric That Actually Means Something

Most of us already understand how skincare actives are communicated. Ten percent niacinamide. Two percent salicylic acid. One percent retinyl acetate. These percentages are the standard language of formulation - they tell you how much of an active ingredient is present in the total formula, and they make it possible to compare products, understand dosing, and interpret clinical data with confidence.

Exosome concentration works the same way. When a product states that it contains 1% Cica Exosome complex, that means 1% of the total formula by weight consists of the active exosome complex. In a 30ml bottle, 1% translates to 0.3ml of active material - a meaningful, standardised, and reproducible quantity that a formulator can verify, a clinical researcher can test, and a consumer can actually use as a reference point.

This is the language of formulation science. It is how every other active ingredient in your skincare routine is measured and understood. The argument for applying the same standard to exosomes is not complicated: if concentration is how we evaluate retinol, hyaluronic acid, peptides, and vitamin C, it should be how we evaluate exosomes too. The ingredient being new to skincare does not change the logic of measurement.

Contrast this with particle count. “Billions of exosomes” tells you how many particles a brand claims are present in the product. It says nothing about the functional viability of those particles, the biological activity they carry, the stability of the formula, the source quality, or the supporting ingredient matrix. Particle count is a number without context. Concentration is a number with meaning.

The reason the exosome market has defaulted to particle count claims is not scientific - it is commercial. The industry is new. Standardised communication around exosome dosing has not yet been established. That vacuum has been filled by marketing language designed to impress rather than inform. Big numbers communicate potency. They just do not communicate it accurately.

The American Society of Plastic Surgeons recognises exosomes as a genuinely exciting breakthrough in skincare - and notes specifically that consumers benefit from sourcing products from transparent providers who can speak clearly to sourcing and clinical evidence. Concentration, stated as a percentage, is the foundation of that transparency. For a deeper dive into how exosomes function at a cellular level - including the biology of how they carry and deliver their signalling payload - The Science Behind Exosomes: How Your Skin’s Cellular Messaging System Works covers the full biology, from lipid bilayer structure to biogenesis.

The takeaway from this section is simple: concentration is a formulator’s metric, and it is the right one to use when evaluating an exosome serum. Explore the full INKEY exosome ingredient guide for the complete ingredient-level breakdown. The question that follows naturally is why particle count fails - and that is a more involved story than most product pages are willing to tell.

Why “Billions of Exosomes” Is a Misleading Marketing Claim

This is the most important section of this blog for anyone who has looked at an exosome serum and seen a large particle count printed prominently on the packaging. The issue is not just that the number is hard to interpret. The issue is that the number is structurally unreliable - and the science explains exactly why.

The Measurement Problem: NTA vs TRPS

There is no single standardised method for counting exosomes. Two of the most widely used techniques - Nanoparticle Tracking Analysis (NTA) and Tunable Resistive Pulse Sensing (TRPS) - are both legitimate scientific tools, but they produce different counts from the same sample. NTA works by tracking the movement of light-scattering particles in suspension and inferring size and concentration from that movement. TRPS works by measuring electrical resistance as particles pass through a nanopore of a known size.

These are different physical measurement principles. They respond differently to particle aggregation, to the concentration of the sample at measurement time, and to particles that sit at the margins of the exosome size range (roughly 30-150 nanometres). A brand using NTA to count particles in one batch and a competitor using TRPS to count particles in another batch will produce different numbers - even if the underlying biological content of the two products is identical. Cross-brand comparisons of particle counts are, therefore, scientifically meaningless.

Not Every Counted Particle Is a Functional Exosome

This is the second and equally critical problem. Both NTA and TRPS count all particles within the detectable size range. That includes debris from the manufacturing process, lipid droplets that are not exosomes, and other non-exosomal vesicles that share the same general size profile as genuine exosomes. A product claiming 10 billion particles may contain a significant proportion of particles with no biological signalling activity whatsoever.

Published research on plant-derived exosome concentrations demonstrates just how wide the range of measurable particle concentrations can be from the same type of plant material - ranging from 2.2 x 10^8 to 4.3 x 10^9 particles per millilitre across different plant sources and extraction conditions. That is more than a tenfold difference, and it reflects how much the measurement outcome depends on extraction method, measurement technique, and sample preparation - not on the functional potency of the exosome content.

Degradation Between Batch and Bathroom

Exosome particle counts are typically measured at the point of production - immediately after isolation and before the product goes through filling, packaging, storage, and distribution. Exosomes are biologically active structures. They degrade. The count that exists in a freshly isolated batch is not the count that exists in the product by the time it reaches the consumer’s bathroom shelf. A product that claims “5 billion exosomes” is likely citing a figure from the production batch measurement, not a figure that reflects the viable exosome content at point of use.

This is not a minor caveat. It is a structural weakness in how particle count is used as a marketing claim, and it is one that concentration-based measurement partially addresses - because 1% concentration is a formulation standard that speaks to how the product is designed, not just how it measured out of the centrifuge.

The Sand and Gold Analogy

A useful way to think about the limits of particle count: imagine being told a bucket contains 5 billion grains of material. That number alone tells you nothing about whether the bucket contains sand or gold. Knowing the count does not tell you what is being counted, how active it is, or whether any of it is doing useful work. Particle count in exosome skincare is the same. The number without context - without concentration, source, viability data, and clinical testing - is closer to marketing than to science.

“It isn’t easy for a consumer to know which exosome skincare brand to buy… I sought companies that were transparent about their sourcing information, specifically where the exosomes originated. I also wanted clinical evidence demonstrating the effectiveness of their product.” American Society of Plastic Surgeons patient article, June 2025

Our blog 5 Exosome Skincare Myths Debunked covers the broader picture of “more is better” misconceptions in exosome skincare. This blog goes significantly further on the measurement science specifically - the NTA vs TRPS question, what degradation means for real-world particle counts, and why the label-reading framework in the section below is the practical tool that myth-busting alone cannot provide.

With the core problem established, the next question becomes: if not particle count, then what should a consumer evaluate? The answer starts with where the exosomes come from.

Why Exosome Source Quality Shapes Everything That Follows

Not all exosomes are created equal. Two products may claim the same particle count and the same concentration, but if the exosomes come from fundamentally different sources, they carry fundamentally different biological content, safety profiles, and skin compatibility characteristics. Source is not a detail on the label. It is the foundation on which everything else is built.

The Three Main Sources in Skincare

Plant-derived exosomes are extracted from botanical material - in this case, from Centella Asiatica (Cica). They are vegan, ethically sourced, biocompatible, and studied in peer-reviewed dermatological research. Because they do not originate from human or animal cells, they carry a lower immune reaction risk and are suitable for a wide range of skin types, including sensitive skin. Peer-reviewed research on plant-derived exosome-like nanovesicles for skin conditionsconfirms their growing body of evidence in dermatological applications.

Animal-derived exosomes carry closer biological compatibility to human cells - which sounds like a benefit - but also raise significant ethical concerns and require more complex purification processes to reduce the risk of cross-species contamination or immune reactions.

Human-derived exosomes are theoretically the most biologically compatible. In practice, they raise serious safety, contamination, and ethical questions that make them entirely inappropriate for mass-market cosmetic use. They are not a category that belongs in a product you purchase from a shelf.

Why Centella Asiatica Specifically

Cica has decades of clinical research behind it as a skin-calming, barrier-supporting, and collagen-stimulating botanical. This is not a background ingredient - it is one of the most substantively researched botanicals in dermatology. Cica-derived exosomes carry the cellular signalling properties inherent to exosomes as a class, combined with the specific biological content of their Centella Asiatica source. Published PubMed research on Centella Asiatica exosome nanovesicles confirms their scientific validity as a source material for skincare applications.

This source-specificity matters. Research published in Applied Biological Chemistry confirms that plant exosomes carry source-specific biological effects - the exosomes derived from ginseng affected keratinocyte gene expression in ways that differed from those derived from green tea, which differed from those derived from Cica. Exosomes carry the biological identity of their source material. What you choose as a source plant is not a branding decision. It is a formulation decision with direct implications for what the exosomes can do.

Size and Penetration

Exosomes are approximately 30-150 nanometres in diameter. To put that in a skin context, that is approximately 300 times smaller than a single pore. This is a biological property, not a marketing claim - it is documented in peer-reviewed research on exosome characterisation. This scale is what allows topical exosome serums to deliver their cellular signals to skin cells without clinical procedures, injections, or needles. The size advantage is real. But it only means something if the exosomes being applied are biologically active and correctly formulated - two conditions that particle count alone does not address.

The 3 Million Figure in Context

Our Exosome Glow Serum (£20 / 30ml) contains 3 million Cica-derived exosomes per bottle. That figure is shared in the spirit of transparency - not as a superiority claim over other particle counts. What makes it meaningful is what accompanies it: a stated 1% concentration standard, a named plant source, and clinical testing of the complete formula. Three million Cica exosomes in a clinically validated formula is a different proposition from “5 billion uncounted particles” in a product with no named source and no clinical data.

For readers curious about how exosome source science compares to another next-generation cellular renewal ingredient, PDRN vs Exosomes - What’s the Difference? covers both categories by mechanism, so you can understand the distinctions clearly.

Knowing where exosomes come from is one piece of the puzzle. But the formula surrounding them determines whether that source quality is amplified or wasted.

Why Supporting Ingredients Make or Break an Exosome Serum

Here is a point that even engaged skincare consumers often miss: exosomes do not work in isolation. They function as biological messengers - signalling cells to renew, repair, increase collagen production, and reduce inflammatory activity. But whether those signals reach cells in optimal conditions, and whether the skin around them can respond to those signals effectively, depends entirely on the formula they live in.

A product that claims 10 billion exosomes but contains no supporting hydrators, no barrier actives, and no collagen-support ingredients may deliver significantly less visible benefit than a 1% concentration exosome serum with a carefully designed supporting matrix. This is not speculation. Research published in MDPI Cosmetics demonstrates that well-designed supporting matrices can increase the bioavailability of exosome activity by 200-300% compared to standalone preparations. Formulation science is not a supporting act. It is a multiplier.

The Five Supporting Ingredients in Our Exosome Glow Serum

Our Exosome Glow Serum (£20 / 30ml) is formulated with five active co-ingredients, each chosen for a specific and complementary role in amplifying the core exosome activity:

1% Hyaluronic Acid (multi-molecular): Delivers hydration across multiple skin layers - from the surface to deeper levels - creating a moisture-rich environment that optimises exosome signalling and absorption. Applying the serum to damp skin amplifies this effect significantly, as the hyaluronic acid draws existing moisture into the skin rather than pulling from deeper layers.
1% Ectoin: A clinically studied extremophile molecule that strengthens the skin’s moisture barrier and locks in hydration for up to 12 hours (clinical study of 31 people). This matters for exosome activity because a compromised, stressed skin barrier means the cellular renewal signals from exosomes are working in suboptimal conditions. A strong, hydrated barrier means those signals reach skin cells that are prepared to respond.
1% Kollaren (Tripeptide-1): A clinically studied peptide that directly supports firmness and skin structure. This works synergistically with the collagen-boosting cellular signals from the Cica Exosome complex - the exosomes tell cells to produce more collagen, and the Kollaren supports the structural environment in which that collagen can function most effectively.
Prickly Pear Extract: Gently resurfaces skin for smoother texture and improved radiance. This enhances the visible glow effect that the exosome-driven cellular renewal activity produces - bridging the gap between what is happening at a cellular level and what the skin looks and feels like at the surface.
Q10 (Ubiquinone): A powerful antioxidant that defends against the daily environmental stressors - pollution, UV, oxidative stress - that counteract the cellular renewal signals exosomes send. Without antioxidant protection in the formula, environmental damage can undermine the very renewal activity the exosome complex is driving.

This combination is not accidental. Each ingredient was chosen because it supports, strengthens, or amplifies a specific dimension of the exosome renewal process. Research on exosome treatments and wound healing confirms that the regenerative and repair signalling exosomes provide can accelerate skin healing outcomes by 30-40% in clinical settings - outcomes that depend not just on the exosome biology, but on the condition of the skin environment those signals are working within.

For readers interested in extending this logic beyond the formula itself - into a full skincare routine that amplifies exosome results - Boost Your Retinol Results with Exosome covers how exosomes and retinol work together as a powerful pairing.

The practical implication of this section is clear: when evaluating an exosome serum, the ingredient list matters as much as the exosome claim on the front of the pack. A strong supporting formula is the difference between cellular renewal signals that land effectively and cellular renewal signals that land in stressed, unprepared skin.

Understanding what a well-formulated exosome serum looks like is one thing. Understanding how to evaluate the evidence that it actually works is the next step.

What Clinical Proof Really Looks Like in Exosome Skincare

The phrase “clinically proven” appears on more product packaging than it has any right to. In the absence of clarity about what was tested, on how many people, for how long, and using what methodology, “clinically proven” is close to meaningless. This section breaks down what evidence actually looks like in exosome skincare - so you can read any brand’s claims with the same level of scrutiny.

The Three Tiers of Evidence

In vitro testing refers to tests conducted on skin cells or tissue samples in a laboratory environment. This type of testing is powerful for understanding biological mechanisms - it allows researchers to isolate specific cellular responses and measure them precisely, without the confounding variables present in a full human skin system. Results are typically expressed as percentage improvements in gene expression or marker activity. In vitro results are meaningful. They are mechanistic proof - evidence that a specific biological process is occurring. They are not the same as clinical results on real human skin.

Clinical studies are conducted on real human subjects, under controlled conditions, measuring visible and measurable skin outcomes - hydration levels, wrinkle depth, luminosity, firmness - over a defined period of time. A well-designed clinical study with a statistically meaningful sample and a clear measurement protocol is the gold standard for skincare efficacy evidence. When reading clinical claims, look for study size, study duration, and whether the claim was generated from testing the full product formula or just an isolated ingredient.

Consumer perception panels involve self-reported feedback from participants after using a product. These panels are genuinely useful for understanding real-world experience and user satisfaction. They are less rigorous than clinical measurement, because they rely on subjective assessment rather than objective testing.

INKEY’s Evidence, Attributed Clearly

Transparency about evidence type is itself a quality signal. Here is exactly what each claim about our Exosome Glow Serum is based on:

“Approximately 300% increase in genes related to collagen production” - in vitro testing of Cica Exosomes. This is mechanism-level proof: the biological machinery for collagen production is being activated at the cellular level.
“55% reduction in pro-inflammatory markers” - in vitro testing of Cica Exosomes. Mechanism-level evidence for the anti-inflammatory signalling activity of the Cica Exosome complex.
“63% increase in skin renewal markers in 8 hours” - in vitro testing of Cica Exosomes. Rapid-onset mechanism evidence for cellular turnover acceleration.
“100% saw more glowing skin” - 4-week clinical study of 26 people. Human subjects, controlled conditions, measured outcomes.
“6-in-1 improvement across radiance, hydration, tone, firmness, elasticity, and texture” - 4-week clinical study of 26 people.
“Up to 12 hours hydration” - clinical study of 31 people.

A peer-reviewed systematic review published in Aesthetic Surgery Journal confirms that topical exosome products have demonstrated measurable improvements in facial ageing metrics - including erythema, colour evenness, luminosity, wrinkling, and firmness - in controlled human studies. The evidence base for topical exosome efficacy is real. What matters is whether a specific brand’s evidence is clearly attributed, type-identified, and honest about what was tested.

The INKEY standard is to state the evidence type explicitly - “in vitro testing of Cica Exosomes” rather than the catch-all “clinically proven.” This is what no-BS skincare looks like in practice. The 5 Exosome Skincare Myths Debunkedblog addresses the related question of what regulatory status actually means for consumers in this space.

With the ability to evaluate concentration, source, supporting formula, and clinical evidence, the practical question is: how do you actually apply this at point of purchase? The next section gives you the framework.

How to Read an Exosome Serum Label: A 5-Step Practical Framework

This is the checklist you apply every time you encounter a new exosome serum, whether it is on a website, in a store, or in a brand’s social media advertising. It takes less than two minutes. It tells you more than any headline particle count claim ever will.

Step 1 - Find the concentration percentage. Is the exosome complex listed as a percentage of the total formula? If only a particle count is stated, ask why the percentage is absent. A brand that knows its exosome concentration and is confident in its formulation has no reason to hide that number. Look for a minimum of 1% active exosome complex, stated clearly on the product page or packaging. Anything less than this disclosure warrants scepticism.

Step 2 - Identify the source by name. Is the exosome source named specifically? Is it plant-derived, animal-derived, or human-derived? Does the brand name the specific botanical or cell source - for example, Centella Asiatica? Vague terms like “proprietary exosome blend” or “advanced exosome technology” without a named source indicate that the brand either does not want you to know where the exosomes come from, or that the sourcing information is not something they consider a strength. Both are red flags.

Step 3 - Check the supporting formula. Scroll past the hero ingredient claim and look at the full ingredient list. Are there supporting hydrators, barrier-active ingredients, and cellular renewal boosters alongside the exosome complex? At minimum, look for hyaluronic acid or another humectant, a peptide, and an antioxidant. An exosome-only formula with no supporting matrix is likely underperforming relative to its potential. Exosomes signal. A good formula ensures those signals land in prepared, supported skin.

Step 4 - Evaluate the evidence type and quality. What kind of evidence is cited? In vitro, clinical, or consumer panel? If clinical: how many participants? Over what period? Is the claim made for the full formula, or only for an isolated ingredient? A brand that is specific about these details is a brand that has thought carefully about what its evidence actually proves. A brand that simply says “clinically proven” without attribution is asking you to take their word for it.

Step 5 - Look for stability and viability disclosure. This is rare - but when a brand discloses something about exosome stability and viability within the formula, it is a significant signal. It means the team building the product has thought beyond the production batch count and considered what the exosome content looks like at the point the consumer actually opens the bottle. It marks a science-led brand rather than a marketing-led one.

The “Billions” Red Flag

If the primary claim on a product is a particle count - with no stated concentration percentage, no named source, no ingredient matrix information, and no attributed clinical data - treat that as a signal. The product may well contain exosomes. But the brand has chosen to communicate in the least informative way possible. That is a formulation and transparency choice, and it is worth taking seriously.

What Good Looks Like

A brand that states “1% Cica Exosome complex, plant-derived from Centella Asiatica, clinically tested to improve radiance, hydration, tone, firmness, elasticity, and texture over a 4-week clinical study of 26 people” is giving you everything you need. A named source. A stated concentration. A specific study design. Attributed evidence types. For readers who want the deeper biological context behind each of these label elements, The Science Behind Exosomes: How Your Skin’s Cellular Messaging System Works covers the cellular biology, and the full INKEY exosome ingredient guide provides the ingredient-level detail.

This framework is not complicated to apply. It is, however, exactly the framework that most brands are hoping you do not use.

The INKEY Approach: Transparency in Practice and How to Get the Most From Your Serum

Part A: How INKEY Applies the Framework

Our Exosome Glow Serum (£20 / 30ml) was built around exactly the principles this blog has outlined. Here is how each criterion is met:

Concentration: 1% Cica Exosome complex - stated clearly on the product page and packaging. Not a particle count. A formulation standard.

Source: Plant-derived from Centella Asiatica. Vegan, fragrance-free, and ethically sourced. Centella Asiatica is one of the most extensively studied botanicals in dermatology, with decades of peer-reviewed research confirming its skin-calming, barrier-supporting, and collagen-stimulating properties. The exosomes derived from it carry that biological heritage.

Scale: Approximately 300 times smaller than a pore - enabling deep topical penetration without clinical intervention. This is a biological property of exosome-sized vesicles (30-150 nanometres), not a marketing claim.

Transparency on particle count: 3 million Cica-derived exosomes per bottle. This figure is shared not as a superiority claim, but as a transparency measure - a number tied to a known concentration standard and backed by clinical testing of the complete formula.

Supporting formula: Five active co-ingredients - 1% multi-molecular Hyaluronic Acid, 1% Ectoin, 1% Kollaren (Tripeptide-1), Prickly Pear Extract, and Q10 - each functioning synergistically to optimise the environment in which exosome cellular renewal activity occurs.

Clinical evidence, attributed:

Approximately 300% increase in genes related to collagen production (in vitro testing of Cica Exosomes)
55% reduction in pro-inflammatory markers (in vitro testing of Cica Exosomes)
63% increase in skin renewal markers in 8 hours (in vitro testing of Cica Exosomes)
100% of participants saw more glowing skin (4-week clinical study, 26 people)
6-in-1 improvement in radiance, hydration, tone, firmness, elasticity, and texture (4-week clinical study, 26 people)
Up to 12 hours hydration (clinical study, 31 people)

Ethical formulation: B Corp certified, vegan, fragrance-free, alcohol-free, paraben-free, and dermatologically tested.

Price: £20 / 30ml. As explored in The Glow Revolution, INKEY’s position from the beginning has been that clinic-level ingredient science should not require clinic-level pricing. That principle applies directly here.

Part B: How to Get the Most From Your Exosome Glow Serum

Using the Exosome Glow Serum correctly makes a measurable difference to the results you see. Here is how:

Apply to damp skin immediately after cleansing, before other serums. Step 2 in your routine. Damp skin amplifies the effect of the multi-molecular hyaluronic acid in the formula, locking hydration in rather than drawing from within.

A pea-sized amount is enough to cover the full face and neck. This is a concentrated formula. More product does not mean more benefit - it means less value from your bottle.

Use AM and PM for consistent cellular renewal signalling. Exosome activity works cumulatively. Once-daily use will give you results; twice-daily use builds them faster and more consistently.

For an additional cellular renewal boost: the Exosome Boosting Dry Sheet Masks - Pack of 3 (£20) uses OXYGESKIN technology to boost the skin’s own exosome activity. Use as a 10-minute weekly or pre-event treatment on top of your regular serum routine.

Layer with our Bio-Active Ceramide Moisturiser (£19) to seal in the renewal benefits and actively support barrier function. Ceramides reinforce the barrier through which the exosome signals are working - this is not just a routine step, it is a functional addition to the exosome benefit.

On timing: cellular renewal effects build over 14 days. Day one will deliver a visible glow - the immediate hydration and luminosity from the formula is noticeable from first use. The full 6-in-1 clinical results - improvements in radiance, tone, firmness, elasticity, and texture - are measured at the 14-day mark with continued use. Consistency is the mechanism.

On stacking: the PDRN Serum (£18) represents another science-led cellular renewal option for readers who want to explore the broader next-generation renewal category. For a full comparison of how PDRN and exosomes differ by mechanism, PDRN vs Exosomes - What’s the Difference? covers the science clearly.

Build your exosome routine and save up to 20% - the routine builder makes it straightforward to combine the serum, masks, and moisturiser at a better price than purchasing separately.

The Final Verdict: Five Things That Actually Matter in an Exosome Serum

The exosome skincare category is genuinely innovative. The science behind exosomes as cellular messengers is real, peer-reviewed, and rapidly expanding. A systematic review published in Aesthetic Surgery Journal confirms that topical exosome products have demonstrated measurable outcomes including improvements in radiance, luminosity, colour evenness, wrinkling, and firmness in controlled human studies. This is a category worth paying attention to.

But like any new skincare technology, it benefits from scrutiny. And the most important act of scrutiny a consumer can apply is to look past the particle count and ask the right questions instead.

The five things that actually matter when choosing an exosome serum:

Stated concentration percentage - not a particle count, a formulation standard
Named source - plant-derived, specifically identified (not “proprietary blend”)
Supporting ingredient matrix - hydrators, barrier actives, and cellular renewal boosters alongside the exosome complex
Attributed evidence - in vitro testing distinguished clearly from clinical studies, with study size and duration stated
Transparent brand communication - a brand willing to tell you exactly what they measured, and how

Affordable does not mean inferior. Clinical formulation and accessible pricing can co-exist. Our Exosome Glow Serum is £20 for 30ml. That price is not a compromise. It is a position. For readers building a full routine around exosome skincare within a budget, The Broke Girl’s Guide to Glass Skin offers a practical starting point.

The billion-particle era of exosome marketing will pass. What will remain - and what already separates effective products from impressive-sounding ones - is concentration, source, formulation, and clinical proof. Now you know exactly what to look for.